Literature DB >> 28323147

Increase of circulating α4β7+ conventional memory CD4 and regulatory T cells in patients with common variable immunodeficiency (CVID).

Karina Mescouto de Melo1, Susanne Unger1, Baerbel Keller1, Sylvia Gutenberger1, Ina Stumpf1, Sigune Goldacker1, Klaus Warnatz2.   

Abstract

This study investigated whether circulating α4β7+ expressing T cells could serve as a potential marker for gastrointestinal (GI) disease activity in patients with CVID. The analysis of α4β7+ T cells in the peripheral blood of 36 patients and 22 healthy donors (HD) revealed increased percentages of α4β7+ conventional memory CD4 T cells and Tregs, but not among CD8 T-cell populations in patients with CVID compared to HD. No differences between patients with and without chronic or acute GI symptoms were observed. EUROClass smB- and 21lo patients, had higher percentages of α4β7+ memory CD4 T cells compared to HD and smB+ or 21norm patients, respectively. In summary, the detection of α4β7+ T cells in the peripheral blood did not correlate with active or chronic gastrointestinal disease. The increase of these cells in smB- and 21lo patients adds another piece to the immune dysregulation observed in these patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Common variable immunodeficiency; Diagnostics; Enteropathy; Homing; T cell; α4β7

Mesh:

Substances:

Year:  2017        PMID: 28323147     DOI: 10.1016/j.clim.2017.03.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  2 in total

1.  Vedolizumab therapy in common variable immune deficiency associated enteropathy: A case series.

Authors:  Travis Sifers; Robert Hirten; Saurabh Mehandru; Huaibin Mabel Ko; Jean-Frederic Colombel; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2020-02-11       Impact factor: 3.969

2.  Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency.

Authors:  Bertram Bengsch; Klaus Warnatz; Adam Klocperk; David Friedmann; Alexandra Emilia Schlaak; Susanne Unger; Zuzana Parackova; Sigune Goldacker; Anna Sediva
Journal:  J Clin Immunol       Date:  2022-05-19       Impact factor: 8.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.